Yashar Eshraghi, MD
Pain Medicine · New Orleans, LANPI 1710129986
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.2%. Reporting peaked in 2023 at $6,805 and has fallen 64.7% since, to $2,403 in 2025. Among pain medicine clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $111.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$5K
- SPR Therapeutics, Inc$3K
- Medtronic$3K
- Relievant Medsystems, Inc.$2K
- Boston Scientific$2K
- Abbott$2K
- plus $5K from 14 others
Across 50 payments — averaging $6722.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avanos Medical$215K
- SPR Therapeutics, Inc$111K
- Biohaven Pharmaceutical Holding Company Ltd.$7K
- Biohaven Pharmaceuticals, Inc.$3K
- Saluda Medical Americas, Inc.$298
- Abbott$92
What the payments were for
- Consulting fees$5,41325%
- Travel & lodging$3,88418%
- Food & beverage$12,20657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 14 | $4,550 |
| SPR Therapeutics, Inc | 17 | $3,307 |
| Medtronic | 31 | $2,582 |
| Relievant Medsystems, Inc. | 19 | $2,316 |
| Boston Scientific | 28 | $2,076 |
| Abbott | 24 | $1,985 |
| Nevro Corp. | 28 | $1,630 |
| Nalu Medical, Inc. | 8 | $896 |
| MML US, Inc. | 3 | $481 |
| Avanos Medical | 5 | $439 |
| Biotronik NRO, Inc. | 2 | $271 |
| Averitas Pharma Inc. | 3 | $233 |
| Si-bone, Inc. | 2 | $167 |
| Painteq LLC | 1 | $166 |
| Spine Wave, Inc. | 1 | $115 |
| Tersera Therapeutics LLC | 1 | $113 |
| ALON Medical Technology | 1 | $101 |
| AbbVie | 2 | $36 |
| GRT US Holding, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke SCS$3,972
- SPRINT PNS System$3,031
- Intracept$2,695
- INTELLIS ADAPTIVESTIM$1,515
- Proclaim Family of SCS IPGs$807
- Nalu Neurostimulation System$717
- WaveWriter Alpha Prime 16$553
- Evoke$523
- Omnia$483
- ReActiv8$481
- KYPHON EXPRESS II KYPHOPAK TRAY$314
- ETERNA$310
- PROCLAIM$296
- CLINICAL TRIAL PRODUCT$290
- Prospera$271
- Senza Spinal Cord Stimulation System$262
- Senza$237
- PAINTEQ$166
- GENERATOR$158
- Superion Indirect Decompression System$145
How this compares
$21,502 in reported general payments places this provider in the 90th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 634 | $17,931 |
| Xtampza ErOxycodone Myristate | 14 | $14,508 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 576 | $13,012 |
| Pregabalin | 315 | $5,479 |
| Gabapentin | 149 | $1,909 |
| Lidocaine | 16 | $1,874 |
| Tramadol Hcl | 210 | $1,710 |
| Oxycodone Hcl | 82 | $1,474 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 42 | $1,103 |
| Morphine Sulfate ErMorphine Sulfate | 36 | $917 |
| Tizanidine Hcl | 76 | $810 |
| Methadone Hcl | 23 | $696 |
| Naloxone Hcl | 11 | $628 |
| Duloxetine Hcl | 31 | $467 |
| Diclofenac Sodium | 18 | $390 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New Orleans
- Alan KayeNew Orleans$76K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Aaron Hanyu-DeutmeyerNew Orleans$17K
- Trevor JohnsonNew Orleans$11K
- Eric RoysterNew Orleans$10K
- Lesley WalshNew Orleans$10K
- Alvah WickboldtNew Orleans$7K
- Arya BekhradiNew Orleans$6K
- Reda TolbaNew Orleans$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.